Catatan episode
Over the past episodes of Reprogrammed, we’ve followed the rapid evolution of CAR T cell therapy—from early experiments demonstrating that antibody-based chimeric receptors could trigger T cell activation and IL-2 production, to the incorporation of co-stimulatory domains like CD28 and 4-1BB that dramatically improved T cell survival and cytotoxic efficacy.
In this episode of Reprogrammed, Jack and Annieexplore a pivotal 2014 Science paper by Tran et al.,which presents a landmark case in personalized cancer immunotherapy. Shifting focus from engineered CAR T cells to the body's natural…
Situs: podcasters.spotify.com

